Treatment with intravenous low-molecular-weight iron dextran (LMWID) seems to be an effective alternative for patients with nondialysis chronic kidney disease (ND-CKD) who remain anemic despite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback